Malignant lymphoma, diffuse mixed small and large cell. A clinicopathologic study of 47 cases

Kathy Foucar, James Olen Armitage, Fred R. Dick

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The clinical and pathologic features of 47 cases of malignant lymphoma, diffuse mixed small and large cell (diffuse mixed lymphoma) are described. Diffuse mixed lymphomas contained approximately equal numbers of small and large cells (30–70%) and comprised 6% of all non‐Hodgkin's lymphomas. They occurred in middle‐aged and elderly patients (median age = 63 years), showed a female predominance, and were clinically advanced at presentation. The majority of patients exhibited prominent extranodal disease, which frequently involved multiple unrelated sites and usually occurred in conjunction with nodal disease. A notable morphologic spectrum of lymphoma was seen within this series, including 20 cases of mixed small cleaved and large cell (with cleaved and noncleaved nuclei), eight cases of mixed small lymphocytic and large cell (transformed prolymphocytes and blast‐like cells), and 12 cases of mixed small cell and large cell, “immunoblastic” lymphoma (with plasmacytoid, clear cell or hyperconvoluted features). There was no significant difference in response to treatment and survival between those cases with less than 50% large cells and those with greater than 50% large cells. The poorest treatment response appeared to be in patients with mixed small cell and large cell, “immunoblastic” lymphomas. Patients with diffuse mixed lymphoma appeared to show a favorable response to cyclphosphamide, Adriamycin, vincristine, and prednisone (CHOP) and an unfavorable response to other treatment modalities.

Original languageEnglish (US)
Pages (from-to)2090-2099
Number of pages10
JournalCancer
Volume51
Issue number11
DOIs
StatePublished - Jan 1 1983

Fingerprint

Lymphoma
Non-Hodgkin's Lymphoma
Large-Cell Immunoblastic Lymphoma
Vincristine
Prednisone
Doxorubicin
Therapeutics
Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Malignant lymphoma, diffuse mixed small and large cell. A clinicopathologic study of 47 cases. / Foucar, Kathy; Armitage, James Olen; Dick, Fred R.

In: Cancer, Vol. 51, No. 11, 01.01.1983, p. 2090-2099.

Research output: Contribution to journalArticle

@article{5ccc0989c2e64abebe6aa6487263faa0,
title = "Malignant lymphoma, diffuse mixed small and large cell. A clinicopathologic study of 47 cases",
abstract = "The clinical and pathologic features of 47 cases of malignant lymphoma, diffuse mixed small and large cell (diffuse mixed lymphoma) are described. Diffuse mixed lymphomas contained approximately equal numbers of small and large cells (30–70{\%}) and comprised 6{\%} of all non‐Hodgkin's lymphomas. They occurred in middle‐aged and elderly patients (median age = 63 years), showed a female predominance, and were clinically advanced at presentation. The majority of patients exhibited prominent extranodal disease, which frequently involved multiple unrelated sites and usually occurred in conjunction with nodal disease. A notable morphologic spectrum of lymphoma was seen within this series, including 20 cases of mixed small cleaved and large cell (with cleaved and noncleaved nuclei), eight cases of mixed small lymphocytic and large cell (transformed prolymphocytes and blast‐like cells), and 12 cases of mixed small cell and large cell, “immunoblastic” lymphoma (with plasmacytoid, clear cell or hyperconvoluted features). There was no significant difference in response to treatment and survival between those cases with less than 50{\%} large cells and those with greater than 50{\%} large cells. The poorest treatment response appeared to be in patients with mixed small cell and large cell, “immunoblastic” lymphomas. Patients with diffuse mixed lymphoma appeared to show a favorable response to cyclphosphamide, Adriamycin, vincristine, and prednisone (CHOP) and an unfavorable response to other treatment modalities.",
author = "Kathy Foucar and Armitage, {James Olen} and Dick, {Fred R.}",
year = "1983",
month = "1",
day = "1",
doi = "10.1002/1097-0142(19830601)51:11<2090::AID-CNCR2820511123>3.0.CO;2-G",
language = "English (US)",
volume = "51",
pages = "2090--2099",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Malignant lymphoma, diffuse mixed small and large cell. A clinicopathologic study of 47 cases

AU - Foucar, Kathy

AU - Armitage, James Olen

AU - Dick, Fred R.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - The clinical and pathologic features of 47 cases of malignant lymphoma, diffuse mixed small and large cell (diffuse mixed lymphoma) are described. Diffuse mixed lymphomas contained approximately equal numbers of small and large cells (30–70%) and comprised 6% of all non‐Hodgkin's lymphomas. They occurred in middle‐aged and elderly patients (median age = 63 years), showed a female predominance, and were clinically advanced at presentation. The majority of patients exhibited prominent extranodal disease, which frequently involved multiple unrelated sites and usually occurred in conjunction with nodal disease. A notable morphologic spectrum of lymphoma was seen within this series, including 20 cases of mixed small cleaved and large cell (with cleaved and noncleaved nuclei), eight cases of mixed small lymphocytic and large cell (transformed prolymphocytes and blast‐like cells), and 12 cases of mixed small cell and large cell, “immunoblastic” lymphoma (with plasmacytoid, clear cell or hyperconvoluted features). There was no significant difference in response to treatment and survival between those cases with less than 50% large cells and those with greater than 50% large cells. The poorest treatment response appeared to be in patients with mixed small cell and large cell, “immunoblastic” lymphomas. Patients with diffuse mixed lymphoma appeared to show a favorable response to cyclphosphamide, Adriamycin, vincristine, and prednisone (CHOP) and an unfavorable response to other treatment modalities.

AB - The clinical and pathologic features of 47 cases of malignant lymphoma, diffuse mixed small and large cell (diffuse mixed lymphoma) are described. Diffuse mixed lymphomas contained approximately equal numbers of small and large cells (30–70%) and comprised 6% of all non‐Hodgkin's lymphomas. They occurred in middle‐aged and elderly patients (median age = 63 years), showed a female predominance, and were clinically advanced at presentation. The majority of patients exhibited prominent extranodal disease, which frequently involved multiple unrelated sites and usually occurred in conjunction with nodal disease. A notable morphologic spectrum of lymphoma was seen within this series, including 20 cases of mixed small cleaved and large cell (with cleaved and noncleaved nuclei), eight cases of mixed small lymphocytic and large cell (transformed prolymphocytes and blast‐like cells), and 12 cases of mixed small cell and large cell, “immunoblastic” lymphoma (with plasmacytoid, clear cell or hyperconvoluted features). There was no significant difference in response to treatment and survival between those cases with less than 50% large cells and those with greater than 50% large cells. The poorest treatment response appeared to be in patients with mixed small cell and large cell, “immunoblastic” lymphomas. Patients with diffuse mixed lymphoma appeared to show a favorable response to cyclphosphamide, Adriamycin, vincristine, and prednisone (CHOP) and an unfavorable response to other treatment modalities.

UR - http://www.scopus.com/inward/record.url?scp=0020612031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020612031&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19830601)51:11<2090::AID-CNCR2820511123>3.0.CO;2-G

DO - 10.1002/1097-0142(19830601)51:11<2090::AID-CNCR2820511123>3.0.CO;2-G

M3 - Article

VL - 51

SP - 2090

EP - 2099

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 11

ER -